Table 1.
Variable | Patients with definite neurological disease, N = 117 | Patients with acute CNS disease, n = 75 | Patients with acute PNS disease, n = 42 | p value |
---|---|---|---|---|
Age, mean±SD, years | 55.1±17.2 | 59.5±17.5 | 48.3±14.3 | 0.001 |
Sex, M/F | 61/56 | 41/34 | 20/22 | |
Ratio, % | 52.1/47.9 | 54.7/45.3 | 47.6/52.4 | 0.600 |
Definite COVID-19, n (%) | 55 (47.0) | 23 (30.7) | 32 (76.2) | |
Probable COVID-19, n (%) | 62 (53.0) | 52 (69.3) | 10 (33.8) | 0.0001 |
Presenting of general symptoms, n (%) | ||||
Fever | 101 (86.3) | 70 (93.3) | 31 (73.8 | 0.003 |
Sore throat | 7 (6.0) | 0 (0) | 7 (16.7) | 0.0001 |
Fatigue and malaise | 30 (25.6) | 14 (18.7) | 16 (38.1) | 0.003 |
Headache | 36 (30.8) | 21 (28) | 15 (35.7) | 0.380 |
Dizziness and/or vertigo | 15 (12.8) | 4 (5.3) | 11 (26.2) | 0.001 |
GIT symptoms and signs | 29 (24.8) | 17 (22.7) | 12 (28.6) | 0.321 |
Respiratory symptoms and signs | 100 (85.5) | 60 (80.0) | 40 (95.2) | 0.781 |
CT chest: positive bilateral/unilateral GGO | 98 (83.8) | 69 (87.3) | 29 (69) | 0.043 |
CNS, central nervous system; PNS, peripheral nervous system; GIT, gastrointestinal tract; GGO, ground-glass opacities with consolidation; CT, computed tomography.